Wednesday, 26 October 2011

Delos Liquid



benzoyl peroxide

Dosage Form: topical liquid
Delos™

(3.5% benzoyl peroxide) cleanser


Rx Only


FOR EXTERNAL USE ONLY

Delos Liquid Description


Delos™ (3.5% benzoyl peroxide) cleanser is a topical preparation containing benzoyl peroxide, for use in the treatment of acne vulgaris. Benzoyl peroxide is an oxidizing agent that possesses antibacterial properties and is classified as a keratolytic agent. Benzoyl peroxide (C14H10O4) is represented by the following chemical structure:



Delos™ (3.5% benzoyl peroxide) cleanser contains benzoyl peroxide USP 3.5% as the active ingredient in a formulation consisting of: Cetearyl Alcohol, Ceteareth-20, Citric Acid, Cocamidopropyl Betaine, Cocamine Oxide, Disodium Laureth Sulfosuccinate, Edetate Disodium, Magnesium Aluminum Silicate, Methylparaben, PEG-15 Pentaerythrityl Tetrastearate, PEG-6 Caprylic/Capric Glycerides, PEG-150 Stearate, 2-Phenoxyethanol, Poloxamer 182, Polyethylene, Sodium Polyacrylate, PPG-20 Methyl Glucose Ether, Propylene Glycol, Purified Water, and Xanthan Gum.



Delos Liquid - Clinical Pharmacology


The mechanism of action of benzoyl peroxide is not totally understood but its antibacterial activity against Propionibacterium acnes is thought to be a major mode of action, in addition, patients treated with benzoyl peroxide show a reduction in lipids and free fatty acids, and mild desquamation (drying and peeling activity) with simultaneous reduction in comedones and acne lesions. Little is known about the percutaneous penetration, metabolism, and excretion of benzoyl peroxide, although it has been shown that benzoyl peroxide absorbed by the skin is metabolized to benzoic acid and then excreted as benzoate in the urine. There is no evidence of systemic toxicity caused by benzoyl peroxide in humans.



INDICATIONS & USAGE


Delos™ (3.5% benzoyl peroxide) cleanser is indicated for the topical treatment of acne vulgaris.



Contraindications


These preparations are contraindicated in patients with a history of hypersensitivity to any of their components.



Warnings


When using this product, avoid unnecessary sun exposure and use a sunscreen. Keep out of reach of children.



Precautions



General


For external use only. If severe irritation develops, discontinue use and institute appropriate therapy. After reaction clears, treatment may often be resumed with less frequent application. These preparations should not be used in or near the eyes or on mucous membranes.



Information for Patients


Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. Contact with any colored material (including hair and fabric) may result in bleaching or discoloration. If excessive irritation develops, discontinue use and consult your physician.



Carcinogenesis, Mutagenesis, Impairment of Fertility


Data from several studies employing a strain of mice that are highly susceptible to developing cancer suggest that benzoyl peroxide acts as a tumor promoter. The clinical significance of these findings to humans is unknown. Benzoyl peroxide has not been found to be mutagenic (Ames Test) and there are no published data indicating it impairs fertility.



Pregnancy: Teratogenic Effects: Pregnancy Category C


Animal reproduction studies have not been conducted with benzoyl peroxide. It is not known whether benzoyl peroxide can cause fetal harm when administered to a pregnant woman or can effect reproduction capacity. Benzoyl peroxide should be used by a pregnant woman only if clearly needed. There are no available data on the effect of benzoyl peroxide on the later growth, development and functional maturation of the unborn child.



Nursing Mothers


It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when  benzoyl peroxide is used by a nursing woman.



Pediatric Use


Safety and effectiveness in children have not been established.



Adverse Reactions


Allergic contact dermatitis and dryness have been reported with topical benzoyl peroxide therapy.



Overdosage


If excessive scaling, erythema or edema occurs, the use of these preparations should be discontinued. To hasten resolution of the adverse effects, cool compresses may be used. After symptoms and signs subside, a reduced dosage schedule may be cautiously tried if the reaction is judged to be due to excessive use and not allergenicity.



DOSAGE & ADMINISTRATION


Wash affected areas  Delos™ (3.5% benzoyl peroxide) cleanser once or twice daily, rinse and pat dry; or as directed by your physician.



How is Delos Liquid Supplied


Delos™ (3.5% benzoyl peroxide) cleanser is available in 180 g tube (NDC 49908-123-80).


Store at controlled room temperature: 15° - 30° C (59° - 86° F).


Manufactured for:

Rochester Pharmaceuticals

Rochester, NY 14625

Toll Free: 1-866-458-1772

www.RoshesterPharm.com

www.DelosCleanser.com


September 2010



PACKAGE LABEL



NDC 49908-123-80


For dermatologic use only - Not for ophthalmic use


Rx only


delos™


(3.5% benzoyl peroxide) cleanser


6 oz (180 g)


Usual dosage: Wash affected areas with Delos™ (3.5% benzoyl peroxide) cleanser once or twice daily, rinse and pat dry; or as directed by your physician.


Each gram contains - Active: benzoyl peroxide 3.5%. Inactive: Cetearyl Alcohol, Ceteareth-20, Citric Acid, Cocamidopropyl Betaine, Cocamine Oxide, Disodium Laureth Sulfosuccinate, Edetate Disodium, Magnesium Aluminum Silicate, Methylparaben, PEG-15 Pentaerythrityl Tetrastearate, PEG-6 Caprylic/Capric Glycerides, PEG-150 Stearate, 2-Phenoxyethanol, Poloxamer 182, Polyethylene, Sodium Polyacrylate, PPG-20 Methyl Glucose Ether, Propylene Glycol, Purified Water, and Xanthan Gum.


Avoid application close to the eyes. See package insert for full prescribing information.


Important: Do not use if seal has been punctured or is not visible.


Store at 15°-30°C (59°-86°F)


See crimp for lot no. and expiration date.


Distributed by: Rochester Pharmaceuticals

Rochester, NY 14625 • www.RochesterPharm.com


Rochester™ Pharmaceuticals



NDC 49908-123-80


For dermatologic use only - Not for ophthalmic use


Rx only


delos™


(3.5% benzoyl peroxide) cleanser


6 oz (180 g)


Usual dosage: Wash affected areas with Delos™ (3.5% benzoyl peroxide) cleanser once or twice daily, rinse and pat dry; or as directed by your physician.


Each gram contains - Active: benzoyl peroxide 3.5%. Inactive: Cetearyl Alcohol, Ceteareth-20, Citric Acid, Cocamidopropyl Betaine, Cocamine Oxide, Disodium Laureth Sulfosuccinate, Edetate Disodium, Magnesium Aluminum Silicate, Methylparaben, PEG-15 Pentaerythrityl Tetrastearate, PEG-6 Caprylic/Capric Glycerides, PEG-150 Stearate, 2-Phenoxyethanol, Poloxamer 182, Polyethylene, Sodium Polyacrylate, PPG-20 Methyl Glucose Ether, Propylene Glycol, Purified Water, and Xanthan Gum.


Avoid application close to the eyes. See package insert for full prescribing information.


Important: Do not use if seal has been punctured or is not visible.


Store at 15°-30°C (59°-86°F).


See crimp for lot no. and expiration date.


Distributed by: Rochester Pharmaceuticals

Rochester, NY 14625 • www.RochesterPharm.com


Rochester™ Pharmaceuticals









DELOS  
benzoyl peroxide  liquid










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)49908-123
Route of AdministrationTOPICALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Benzoyl Peroxide (Benzoyl Peroxide)Benzoyl Peroxide35 mg  in 1 g
































Inactive Ingredients
Ingredient NameStrength
Cetostearyl Alcohol 
Polyoxyl 20 Cetostearyl Ether 
Citric Acid Monohydrate 
Cocamidopropyl Betaine 
Cocamine Oxide 
Disodium Laureth Sulfosuccinate 
Edetate Disodium 
Magnesium Aluminum Silicate 
Methylparaben 
Phenoxyethanol 
Poloxamer 182 
Propylene Glycol 
Water 
Xanthan Gum 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
149908-123-801 TUBE In 1 BOXcontains a TUBE
1180 g In 1 TUBEThis package is contained within the BOX (49908-123-80)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/01/1970


Labeler - Rochester Pharmaceuticals (134473771)









Establishment
NameAddressID/FEIOperations
IGI LABORATORIES, INC.011036910MANUFACTURE
Revised: 01/2011Rochester Pharmaceuticals

More Delos Liquid resources


  • Delos Liquid Side Effects (in more detail)
  • Delos Liquid Use in Pregnancy & Breastfeeding
  • Delos Liquid Drug Interactions
  • Delos Liquid Support Group
  • 0 Reviews for Delos - Add your own review/rating


Compare Delos Liquid with other medications


  • Acne
  • Perioral Dermatitis

Sunday, 23 October 2011

Minodronic Acid




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0127657-42-5

Chemical Formula

C9-H12-N2-O7-P2

Molecular Weight

322

Therapeutic Category

Calcium regulator

Chemical Names

(1-Hydroxy-2-imidazol[1,2-a]pyridin-3-ylethylidene)diphosphonic acid

Phosphonic acid, (1-hydroxy-2-imidazo[1,2-a]pyridin-3-ylethylidene)bis-

Foreign Names

  • Acidum minodronicum (Latin)
  • Minodronsäure (German)
  • Acide minodronique (French)
  • Ácido minodrónico (Spanish)

Generic Names

  • Minodronic Acid Hydrate (OS: JAN)
  • ONO 5920 (IS)
  • YH-529 (IS)
  • YM-529 (IS)

Brand Names

  • Bonoteo
    Astellas, Japan


  • Recalbon
    Ono Yakuhin, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 21 October 2011

Heptasan




Heptasan may be available in the countries listed below.


Ingredient matches for Heptasan



Cyproheptadine

Cyproheptadine hydrochloride (a derivative of Cyproheptadine) is reported as an ingredient of Heptasan in the following countries:


  • Indonesia

International Drug Name Search

Thursday, 20 October 2011

Donesyn




Donesyn may be available in the countries listed below.


Ingredient matches for Donesyn



Donepezil

Donepezil is reported as an ingredient of Donesyn in the following countries:


  • Slovakia

Donepezil hydrochloride (a derivative of Donepezil) is reported as an ingredient of Donesyn in the following countries:


  • Ireland

  • Poland

International Drug Name Search

Monday, 17 October 2011

REVATIO




In the US, REVATIO (sildenafil systemic) is a member of the drug class agents for pulmonary hypertension and is used to treat Pulmonary Arterial Hypertension.

US matches:

  • Revatio

  • Revatio Injection

  • Revatio Intravenous

UK matches:

  • Revatio 0.8mg/ml solution for injection (SPC)
  • Revatio 20 mg film-coated tablets (SPC)

Ingredient matches for REVATIO



Sildenafil

Sildenafil is reported as an ingredient of REVATIO in the following countries:


  • Bulgaria

Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of REVATIO in the following countries:


  • Australia

  • Austria

  • Belgium

  • Canada

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Finland

  • France

  • Germany

  • Hungary

  • Ireland

  • Israel

  • Italy

  • Japan

  • Netherlands

  • Norway

  • Romania

  • Singapore

  • Slovakia

  • Slovenia

  • Spain

  • Sweden

  • Switzerland

  • United Kingdom

  • United States

  • Venezuela

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ranitidina Perugen




Ranitidina Perugen may be available in the countries listed below.


Ingredient matches for Ranitidina Perugen



Ranitidine

Ranitidine is reported as an ingredient of Ranitidina Perugen in the following countries:


  • Peru

International Drug Name Search

Saturday, 15 October 2011

Amphotec




In the US, Amphotec (amphotericin b cholesteryl sulfate systemic) is a member of the drug class polyenes and is used to treat Aspergillosis - Invasive, Candida Infections - Systemic, Febrile Neutropenia, Histoplasmosis and Leishmaniasis.

US matches:

  • Amphotec

Ingredient matches for Amphotec



Amphotericin B

Amphotericin B is reported as an ingredient of Amphotec in the following countries:


  • Venezuela

Amphotericin B sodium cholesteryl sulfate complex (a derivative of Amphotericin B) is reported as an ingredient of Amphotec in the following countries:


  • United States

International Drug Name Search

Thursday, 13 October 2011

Bacqure




Bacqure may be available in the countries listed below.


Ingredient matches for Bacqure



Cilastatin

Cilastatin sodium salt (a derivative of Cilastatin) is reported as an ingredient of Bacqure in the following countries:


  • China

  • Peru

Imipenem

Imipenem is reported as an ingredient of Bacqure in the following countries:


  • Peru

International Drug Name Search

Tuesday, 11 October 2011

Sympal




Sympal may be available in the countries listed below.


Ingredient matches for Sympal



Dexketoprofen

Dexketoprofen tromethamine (a derivative of Dexketoprofen) is reported as an ingredient of Sympal in the following countries:


  • Germany

International Drug Name Search

Monday, 10 October 2011

Uromitan




Uromitan may be available in the countries listed below.


Ingredient matches for Uromitan



Mesna

Mesna is reported as an ingredient of Uromitan in the following countries:


  • Turkey

International Drug Name Search

Panomec




Panomec may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Panomec



Ivermectin

Ivermectin is reported as an ingredient of Panomec in the following countries:


  • Ireland

  • Netherlands

  • United Kingdom

International Drug Name Search

Saturday, 8 October 2011

Flukonazol Mylan




Flukonazol Mylan may be available in the countries listed below.


Ingredient matches for Flukonazol Mylan



Fluconazole

Fluconazole is reported as an ingredient of Flukonazol Mylan in the following countries:


  • Sweden

International Drug Name Search

Friday, 7 October 2011

Tracrium




In some countries, this medicine may only be approved for veterinary use.


In the US, Tracrium (atracurium systemic) is a member of the drug class neuromuscular blocking agents.

US matches:

  • Tracrium

UK matches:

  • Tracrium Injection (SPC)

Ingredient matches for Tracrium



Atracurium Besilate

Atracurium Besilate is reported as an ingredient of Tracrium in the following countries:


  • Argentina

  • Australia

  • Austria

  • Bahrain

  • Bangladesh

  • Belgium

  • Brazil

  • Bulgaria

  • Chile

  • Costa Rica

  • Czech Republic

  • Dominican Republic

  • Ecuador

  • Egypt

  • El Salvador

  • Estonia

  • France

  • Georgia

  • Germany

  • Greece

  • Guatemala

  • Guyana

  • Honduras

  • Hong Kong

  • Hungary

  • India

  • Indonesia

  • Iran

  • Iraq

  • Israel

  • Italy

  • Jordan

  • Kuwait

  • Latvia

  • Lebanon

  • Lithuania

  • Luxembourg

  • Malaysia

  • Malta

  • Mexico

  • New Zealand

  • Nicaragua

  • Oman

  • Panama

  • Peru

  • Philippines

  • Poland

  • Portugal

  • Qatar

  • Romania

  • Russian Federation

  • Saudi Arabia

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Syria

  • Taiwan

  • Thailand

  • Tunisia

  • Turkey

  • United Arab Emirates

  • United Kingdom

  • United States

  • Vietnam

  • Yemen

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 5 October 2011

Oxymétazoline




Oxymétazoline may be available in the countries listed below.


Ingredient matches for Oxymétazoline



Oxymetazoline

Oxymétazoline (DCF) is known as Oxymetazoline in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 4 October 2011

Glufast




Glufast may be available in the countries listed below.


Ingredient matches for Glufast



Mitiglinide

Mitiglinide calcium hydrate (a derivative of Mitiglinide) is reported as an ingredient of Glufast in the following countries:


  • Japan

  • South Korea

International Drug Name Search

Carboplatino Sidus




Carboplatino Sidus may be available in the countries listed below.


Ingredient matches for Carboplatino Sidus



Carboplatin

Carboplatin is reported as an ingredient of Carboplatino Sidus in the following countries:


  • Argentina

International Drug Name Search

Monday, 3 October 2011

ratio-Alendronate




ratio-Alendronate may be available in the countries listed below.


Ingredient matches for ratio-Alendronate



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of ratio-Alendronate in the following countries:


  • Canada

International Drug Name Search